comparemela.com

Latest Breaking News On - William guyer - Page 1 : comparemela.com

Mutual Advisors LLC Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)

Mutual Advisors LLC Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Illinois
United-states
Cambridge
Cambridgeshire
United-kingdom
Montreal
Quebec
Canada
Sean-maduck
William-guyer
Mutual-advisors
Cambridge-investment-research-advisors-inc

Corcept Therapeutics (NASDAQ:CORT) Lifted to Strong-Buy at StockNews.com

StockNews.com upgraded shares of Corcept Therapeutics (NASDAQ:CORT – Free Report) from a buy rating to a strong-buy rating in a research note published on Saturday morning. Several other equities research analysts have also commented on the stock. Truist Financial lifted their price target on shares of Corcept Therapeutics from $36.00 to $42.00 and gave the […]

United-states
American
William-guyer
Danieln-swisher-jr
Acadian-asset-management
Corcept-therapeutics-company-profile
Corcept-therapeutics-incorporated
Canaccord-genuity-group
Citigroup-inc
American-century-companies-inc
Jpmorgan-chase-co
Corcept-therapeutics

C M Bidwell & Associates Ltd. Makes New $125,000 Investment in Corcept Therapeutics Incorporated (NASDAQ:CORT)

C M Bidwell & Associates Ltd. bought a new stake in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,606 shares of the biotechnology company’s stock, valued at approximately $125,000. Other hedge […]

United-states
Cambridge
Cambridgeshire
United-kingdom
Montreal
Quebec
Canada
Illinois
William-guyer
Sean-maduck
Nasdaq
Corcept-therapeutics-incorporated

Corcept Therapeutics (NASDAQ:CORT) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Corcept Therapeutics (NASDAQ:CORT – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.25 by $0.03, Briefing.com reports. The company had revenue of $135.41 million for the quarter, compared to analyst estimates of $129.27 million. Corcept Therapeutics had a net […]

United-states
William-guyer
Danieln-swisher-jr
Advisor-group-holdings-inc
Tower-research-capital
Canaccord-genuity-group
Corcept-therapeutics-incorporated
Corcept-therapeutics
Get-free-report
Director-daniel
Financial-advisors
Research-capital

Corcept Therapeutics (NASDAQ:CORT) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS

Corcept Therapeutics (NASDAQ:CORT – Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.25 by $0.03, Briefing.com reports. The company had revenue of $135.41 million for the quarter, compared to analyst estimates of $129.27 million. Corcept Therapeutics had a net […]

United-states
Danieln-swisher-jr
William-guyer
Advisor-group-holdings-inc
Corcept-therapeutics-incorporated
Canaccord-genuity-group
Tower-research-capital
Corcept-therapeutics
Get-free-report
Director-daniel
Financial-advisors
Research-capital

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.